RSCM
ADAP

Rock Springs Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$595K Hold
2,483,468
0.04% 86
2025
Q1
$489K Hold
2,483,468
0.03% 94
2024
Q4
$1.34M Buy
2,483,468
+58,000
+2% +$31.2K 0.05% 97
2024
Q3
$2.31M Hold
2,425,468
0.08% 96
2024
Q2
$2.36M Hold
2,425,468
0.07% 99
2024
Q1
$3.83M Hold
2,425,468
0.1% 98
2023
Q4
$1.92M Sell
2,425,468
-362,377
-13% -$287K 0.05% 95
2023
Q3
$2.17M Hold
2,787,845
0.06% 98
2023
Q2
$2.58M Hold
2,787,845
0.06% 103
2023
Q1
$3.04M Buy
2,787,845
+111,309
+4% +$121K 0.07% 100
2022
Q4
$3.91M Buy
2,676,536
+318,992
+14% +$466K 0.09% 93
2022
Q3
$2.53M Hold
2,357,544
0.07% 108
2022
Q2
$4.01M Buy
2,357,544
+60,350
+3% +$103K 0.12% 100
2022
Q1
$4.73M Buy
2,297,194
+81,606
+4% +$168K 0.12% 106
2021
Q4
$8.31M Buy
2,215,588
+25,800
+1% +$96.7K 0.19% 98
2021
Q3
$11.3M Buy
2,189,788
+644,788
+42% +$3.33M 0.24% 103
2021
Q2
$6.58M Hold
1,545,000
0.13% 130
2021
Q1
$8.2M Hold
1,545,000
0.18% 122
2020
Q4
$8.33M Sell
1,545,000
-441,910
-22% -$2.38M 0.18% 119
2020
Q3
$15.9M Hold
1,986,910
0.4% 80
2020
Q2
$19.9M Buy
1,986,910
+786,910
+66% +$7.88M 0.55% 62
2020
Q1
$3.26M Buy
1,200,000
+400,000
+50% +$1.09M 0.14% 114
2019
Q4
$960K Sell
800,000
-75,000
-9% -$90K 0.03% 124
2019
Q3
$1.32M Hold
875,000
0.05% 130
2019
Q2
$3.52M Buy
875,000
+75,000
+9% +$302K 0.13% 118
2019
Q1
$3.44M Buy
800,000
+50,000
+7% +$215K 0.13% 112
2018
Q4
$4.31M Hold
750,000
0.2% 103
2018
Q3
$10.2M Hold
750,000
0.37% 84
2018
Q2
$8.9M Sell
750,000
-125,000
-14% -$1.48M 0.34% 93
2018
Q1
$9.83M Hold
875,000
0.42% 80
2017
Q4
$5.85M Hold
875,000
0.27% 102
2017
Q3
$7.17M Hold
875,000
0.33% 88
2017
Q2
$3.93M Hold
875,000
0.2% 106
2017
Q1
$4.82M Buy
875,000
+200,000
+30% +$1.1M 0.28% 90
2016
Q4
$2.73M Hold
675,000
0.18% 102
2016
Q3
$4.76M Sell
675,000
-90,001
-12% -$635K 0.3% 89
2016
Q2
$6.24M Hold
765,001
0.46% 69
2016
Q1
$6.22M Hold
765,001
0.52% 63
2015
Q4
$9.23M Buy
765,001
+8,901
+1% +$107K 0.7% 50
2015
Q3
$9.05M Sell
756,100
-148,900
-16% -$1.78M 0.73% 48
2015
Q2
$16.6M Buy
+905,000
New +$16.6M 1.21% 25